(Q33994359)

30 July 2017

1 reference

title

The modern management of severe aplastic anaemia (English)

1 reference

30 July 2017

Ball SE

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

British Journal of Haematology

30 July 2017

published in

1 reference

30 July 2017

volume

110

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

41-53

1 reference

Pregnancy associated aplastic anaemia: a report of five cases and review of current management

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data. European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Aplastic anaemia in the Northern Region 1971-1978 and follow-up of long term survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Natural history of paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Successful autologous transplantation in a patient with severe aplastic anemia (SAA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Prevention of transfusion-transmitted cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Improved prognosis for acquired aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Bone marrow transplants for paroxysmal nocturnal haemoglobinuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Late clonal complications in severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Thrombopoietin: its role in platelet disorders and as a new drug in clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02081.X

10.1046/J.1365-2141.2000.02081.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference